Skip to main content
SpringerLink
Log in
Book cover

A Treatise on Topical Corticosteroids in Dermatology pp 23–40Cite as

Dermatological Indications and Usage of Topical Corticosteroid

  • Chapter
  • First Online:

Abstract

Practice of dermatology has been revolutionised with the introduction of topical corticosteroids (TCS).The ever-expanding search to maximise their effects while minimising their side effects has been complemented by synthesising newer molecules with modified chemical structures. The TCS are a class of primarily synthetic steroids with profound anti-inflammatory and antipruritic action. With this most sought-after therapeutic property, a long list of “steroid responsive dermatoses” has emerged into contemporary dermatologic practice. Success of treatment however depends on the accurate diagnosis and selection of the appropriate steroid molecule with relevant consideration of the delivery vehicle, potency, frequency of application, site of involvement, duration of treatment, and strict vigil on the side effects. One has to remember that no single agent has been proven to have the best benefit-to-risk ratio. This chapter deals concisely with the aforementioned and specially is directed against TCS abuse.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009;79(2):135–40.

    PubMed  Google Scholar 

  2. Chi CC, Kirtschig G, Aberer W, Gabbud JP, Lipozencić J, Kárpáti S, et al. Guideline on topical corticosteroids in pregnancy. Br J Dermatol. 2011;165(5):943–52.

    Article  CAS  PubMed  Google Scholar 

  3. Murphy VE, Fittock RJ, Zarzycki PK, Delahunty MM, Smith R, Clifton VL. Metabolism of synthetic steroids by the human placenta. Placenta. 2007;28:39–46.

    Article  CAS  PubMed  Google Scholar 

  4. Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand. 2002;81:234–9.

    Article  PubMed  Google Scholar 

  5. Edwards MJ, Agho K, Attia J, Diaz P, Hayes T, Illingworth A, et al. Case–control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet A. 2003;120:459–63.

    Article  Google Scholar 

  6. Chi CC, Mayon-White RT, Wojnarowska FT. Safety of topical corticosteroids in pregnancy: a population-based cohort study. J Invest Dermatol. 2011;131:884–91.

    Article  CAS  PubMed  Google Scholar 

  7. Mahé A, Perret JL, Ly F, Fall F, Rault JP, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg. 2007;101:183–7.

    Article  PubMed  Google Scholar 

  8. Alston SJ, Cohen BA, Braun M. Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics. 2003;111(1):201–3.

    Article  PubMed  Google Scholar 

  9. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol. 1996;35(4):615–9.

    Article  CAS  PubMed  Google Scholar 

  10. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol. 2003;49:96–8.

    Article  PubMed  Google Scholar 

  11. Vázquez-López F, Marghoob AA. Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis. J Am Acad Dermatol. 2004;51:811–3.

    Article  PubMed  Google Scholar 

  12. Wolkerstorfer A, Visser RL, De Waard van der Spek FB, den Hollander JC, Tank B, Oranje AP. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution. Br J Dermatol. 2000;143:999–1004. 38

    Article  CAS  PubMed  Google Scholar 

  13. Devillers AC, de Waard-van der Spek FB, Mulder PG, Oranje AP. Treatment of refractory atopic dermatitis using ‘wet-wrap’ dressings and diluted corticosteroids: results of standardized treatment in both children and adults. Dermatology. 2002;204:50–5.

    Article  CAS  PubMed  Google Scholar 

  14. Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, et al. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010;86:208–13.

    PubMed  Google Scholar 

  15. Stadler JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin Flora in atopic dermatitis. Br J Dermatol. 1994;131:536–40.

    Google Scholar 

  16. Hung SH, Lin YT, Chu CY, Lee CC, Liang TC, Yang YH, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98(1):51–6.

    Article  CAS  PubMed  Google Scholar 

  17. Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164:415–28.

    Article  CAS  PubMed  Google Scholar 

  18. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus Aureus in atopic dermatitis. JAAD. 1992;27(1):29–34.

    Article  CAS  PubMed  Google Scholar 

  19. Gonzalez ME, Schaffer JV, Orlow SJ, Orlow SJ, Gao Z, Li H, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75:481–93.

    Article  CAS  PubMed  Google Scholar 

  20. Glazenburg EJ, Wolkerstorfer A, Gerretsen AL, et al. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls? Pediatr Allergy Immunol. 2009;20:59–66.

    Article  PubMed  Google Scholar 

  21. Callen J, Chamlin S, Eichenfield LF, Mulder PGH, Oranje AP. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007;156:203–21.

    Article  CAS  PubMed  Google Scholar 

  22. Del Rosso JQ. Adult Seborrheic dermatitis. A status report on practical topical management. J Clin Aesthet Dermatol. 2011;4(5):32–8.

    PubMed  PubMed Central  Google Scholar 

  23. Elewski B. An investigator-blinded, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb topical cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face. Clinics Dermatol. 2009;27:S10–5.

    Article  Google Scholar 

  24. Johnson BA, Nunley JR. Treatment of Seborrheic dermatitis. Am Fam Physician. 2000;61(9):2703–10.

    CAS  PubMed  Google Scholar 

  25. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of Seborrheic dermatitis. Am Fam Physician. 2015;91(3):185–90.

    PubMed  Google Scholar 

  26. Milani M, Di Molfetta SA, Gramazio R, Fiorella C, Frisario C, Fuzio E, et al. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients. Curr Med Res Opin. 2003;19(4):342–5.

    Article  CAS  PubMed  Google Scholar 

  27. Ortonne JP, Nikkels AF, Reich K, Ponce Olivera RM, Lee JH, Kerrouche N, et al. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. Br J Dermatol. 2011;165(1):171–6.

    Article  CAS  PubMed  Google Scholar 

  28. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol. 2004;151(5):1071–5.

    Article  CAS  PubMed  Google Scholar 

  29. Firooz A, Solhpour A, Gorouhi F, Daneshpazhooh M, Balighi K, Farsinejad K, et al. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch Dermatol. 2006;142(8):1066–7.

    Article  PubMed  Google Scholar 

  30. Cicek D, Kandi B, Bakar S, Turgut D. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study. J Dermatolog Treat. 2009;20(6):344–9.

    Article  CAS  PubMed  Google Scholar 

  31. Usatine RP, Riojas M. Diagnosis and Management of Contact Dermatitis. Am Fam Physician. 2010;82(3):249–55.

    PubMed  Google Scholar 

  32. Silverberg NB. Pediatric contact dermatitis treatment and management. Available at http://emedicine.medscape.com/article/911711-treatment#d11. Accessed on 9.1.17.

  33. Levin C, Zhai H, Bashir S, Chew AL, Anigbogu A, Stern R, et al. Efficacy of corticosteroids in acute experimental irritant contact dermatitis? Skin Res Technol. 2001;7(4):214–8.

    Article  CAS  PubMed  Google Scholar 

  34. Baeck M, Chemelle JA, Rasse C, Terreux R, Goossens A. C16 methyl corticosteroids are far less allergenic than the non-methylated molecules. Contact Dermatitis. 2011;64(6):305–12.

    Article  CAS  PubMed  Google Scholar 

  35. Scheinfeld NS. Polymorphous light eruption treatment and management. Drugs & Dis. 2016. Available at http://emedicine.medscape.com/article/1119686-treatment. Accessed 9.1.2017.

  36. Brunner N, Yawalkar S. A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus. J Am Acad Dermatol. 1991;25(6 Pt 2):1160–3.

    Article  CAS  PubMed  Google Scholar 

  37. Datz B, Yawalkar S. A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus. J Am Acad Dermatol. 1991;25(6 Pt 2):1157–60.

    Article  CAS  PubMed  Google Scholar 

  38. Geraldez MC, Carreon-Gavino M, Hoppe G, Costales A. Diflucortolone valerate ointment with and without occlusion in lichen simplex chronicus. Int J Dermatol. 1989;28(9):603–4.

    Article  CAS  PubMed  Google Scholar 

  39. Pinney SS. Pityriasis alba treatment and management. Medscape. Available at http://emedicine.medscape.com/article/910770-treatment.

  40. Harper J. Topical corticosteroids for skin disorders in infants and children. Drugs. 1988;36(Suppl 5):34–7.

    Article  PubMed  Google Scholar 

  41. Lyon CC, Smith AJ, Griffiths CEM, Becka MH. Peristomal dermatoses: a novel indication for topical steroid lotions. J Am Acad Dermatol. 2000;43(4):684–7.

    Article  Google Scholar 

  42. Thomas J, Parimalam K, Sindhu BR. Childhood psoriasis. Expert Rev Dermatol. 2013;8(5):547–56.

    Article  CAS  Google Scholar 

  43. Thomas J, Parimalam K. Treating pediatric plaque psoriasis: challenges and solutions. Pediatr Health Med Ther. 2016;7:25–38.

    Article  Google Scholar 

  44. Kimball AB, Gold MH, Zib B, Davis MW, Clobetasol Propionate Emulsion Formulation Foam Phase III Clinical Study Group. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol. 2008;59:448–54.

    Article  PubMed  Google Scholar 

  45. Pardasani AG, Feldman SR, Clark AR. Treatment of psoriasis: an algorithm-based approach for primary care physicians. Am Fam Physician. 2000;61(3):725–33.

    CAS  PubMed  Google Scholar 

  46. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2009;61(3):451–85.

    Article  CAS  PubMed  Google Scholar 

  47. Lidbrink P, Johannesson A, Hammar H. Psoriasis treatment: faster clearance when UVB-dithranol is combined with topical clobetasol propionate. Dermatologica. 1986;172:164–8.

    Article  CAS  PubMed  Google Scholar 

  48. Petrozzi JW. Topical steroids and UV radiation in psoriasis. Arch Dermatol. 1983;119:207–10.

    Article  CAS  PubMed  Google Scholar 

  49. Larko O, Swanbeck G, Svartholm H. The effect on psoriasis of clobetasol propionate used alone or in combination with UVB. Acta Derm Venereol. 1984;64:151–4.

    CAS  PubMed  Google Scholar 

  50. Dover JS, McEvoy MT, Rosen CF, Arndt KA, Stern RS. Are topical corticosteroids useful in phototherapy for psoriasis? J Am Acad Dermatol. 1989;20:748–54.

    Article  CAS  PubMed  Google Scholar 

  51. Meola T, Soter NA, Lim HW. Are topical corticosteroids useful adjunctive therapies for the treatment of psoriasis with ultraviolet radiation? A review of the literature. Arch Dermatol. 1991;27:1708–13.

    Article  Google Scholar 

  52. van de Kerkhof PC, Kragballe K, Segaert S, Lebwohl M. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the international psoriasis council. J Eur Acad Dermatol Venereol. 2011;25(10):1130–9.

    Article  PubMed  Google Scholar 

  53. Sugerman PB. Oral lichen Planus medication. Medscape Updated: Aug 31, 2016. Available at http://emedicine.medscape.com/article/1078327-medication.

  54. Chuang T-Y. Lichen planus medication. Updated: Mar 01, 2016. Available at http://emedicine.medscape.com/article/1123213-medication.

  55. Sugerman PB. Oral lichen Planus medication. Drugs Dis. 2016. Available at http://emedicine.medscape.com/article/1078327-medication#2. Accessed 9 Jan 2017.

  56. Majid I, Keen A. Management of alopecia areata: an update. BJMP. 2012;5(3):a530.

    Google Scholar 

  57. Charuwichitratana S, Wattanakrai P, Tanrattanakorn S. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream. Arch Dermatol. 2000;136(10):1276–7.

    Article  CAS  PubMed  Google Scholar 

  58. Montes LF. Topical halcinonide in alopecia areata and alopecia totalis. J Cutan Pathol. 1997;4:47–50.

    Article  Google Scholar 

  59. Tan E, Tay YK, Giam YCH. A clinical study of childhood alopecia areata in Singapore. Pediatr Dermatol. 2002;19:298–301.

    Article  PubMed  Google Scholar 

  60. Ross EK, Shapiro J. Management of hair loss. Dermatol Clin. 2005;23:227–43.

    Article  PubMed  Google Scholar 

  61. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549–66.

    Article  CAS  PubMed  Google Scholar 

  62. Tosti A, Iorizzo M, Botta GL, Milani M. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol. 2006;20(10):1243–7.

    Article  PubMed  Google Scholar 

  63. Downs AM, Lear JT, Kennedy CT. Anaphylaxis to intradermal triamcinolone acetonide. Arch Dermatol. 1998;134:1163–4.

    Article  CAS  PubMed  Google Scholar 

  64. Devi M, Rashid A, Ghafoor R. Intralesional triamcinolone Acetonide versus topical betamethasone valerate in the management of localized alopecia areata. J Coll Physicians Surg Pak. 2015;25(12):860–2.

    PubMed  Google Scholar 

  65. Chu TW, AlJasser M, Alharbi A, Abahussein O, McElwee K, Shapiro J. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: an intrasubject pilot study. J Am Acad Dermatol. 2015;73(2):338–40.

    Article  PubMed  Google Scholar 

  66. Chang KH, Rojhirunsakool S, Goldberg LJ. Treatment of severe alopecia areata with intralesional steroid injections. J Drugs Dermatol. 2009;8(10):909–12.

    PubMed  Google Scholar 

  67. Mancuso G, Balducci A, Casadio C, Farina P, Staffa M, Valenti L, et al. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol. 2003;42(7):572–5.

    Article  CAS  PubMed  Google Scholar 

  68. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139(5):581–5.

    Article  CAS  PubMed  Google Scholar 

  69. Wang E, Koo J, Levy E. Intralesional corticosteroid injections for vitiligo: a new therapeutic option. J Am Acad Dermatol. 2014;71(2):391–2.

    Article  PubMed  Google Scholar 

  70. Roenigk HH, Martin JS, Eichorn P, Gilliam JN. Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy. Cutis. 1980;25:281–5.

    PubMed  Google Scholar 

  71. Tzung TY, Liu YS, Chang HW. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. Br J Dermatol. 2007;156:191–2.

    Article  CAS  PubMed  Google Scholar 

  72. Madan V, August PJ, Chalmers RJ. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study. Clin Exp Dermatol. 2010;35:27–30.

    Article  CAS  PubMed  Google Scholar 

  73. Madan V, August PJ, Chalmers RJ, Barikbin B, Givrad S, Yousefi M, et al. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study. Clin Exp Dermatol. 2009;34:776–80.

    Article  Google Scholar 

  74. Eastham ABW. Discoid lupus erythematosus treatment and management. Updated: Feb. http://emedicine.medscape.com/article/1065529-treatment#d10.

  75. Joly P, Fontaine J, Roujeau JC. The role of topical corticosteroids in bullous pemphigoid in the elderly. Drugs Aging. 2005;22(7):571–6.

    Article  CAS  PubMed  Google Scholar 

  76. Dumas V, Roujeau JC, Wolkenstein P, Revuz J, Cosnes A. The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid. Br J Dermatol. 1999;140(6):1127–9.

    Article  CAS  PubMed  Google Scholar 

  77. Abecassis S, Joly P, Genereau T, Courville P, André C, Moussalli J, et al. Superpotent topical steroid therapy for epidermolysis bullosa acquisita. Dermatology. 2004;209:164–6.

    Article  CAS  PubMed  Google Scholar 

  78. Pandey A, Gangopadhyay AN, Sharma SP, Kumar V, Gupta DK, Gopal SC. Evaluation of topical steroids in the treatment of superficial hemangioma. Skinmed. 2010;8(1):9–11.

    PubMed  Google Scholar 

  79. Metry DW. Management of infantile hemangiomas. Available at http://www.uptodate.com/contents/management-of-infantile-hemangiomas.

  80. Garzon MC, Lucky AW, Hawrot A, Frieden IJ. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol. 2005;52:281.

    Article  PubMed  Google Scholar 

  81. Chen MT, Yeong EK, Horng SY. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. J Pediatr Surg. 2000;35:420.

    Article  CAS  PubMed  Google Scholar 

  82. Ceisler EJ, Santos L, Blei F. Periocular hemangiomas: what every physician should know. Pediatr Dermatol. 2004;21(1):1–9.

    Article  PubMed  Google Scholar 

  83. Siddiqi S, Vijay V, Ward M, Mahendran R, Warren S. Pruritus Ani. Ann R Coll Surg Engl. 2008;90(6):457–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Webster TM, Leonard MP. Topical steroid therapy for phimosis. Can J Urol. 2002;9(2):1492–5.

    PubMed  Google Scholar 

  85. Lund L, Wai KH, Mui LM, Yeung CK. Effect of topical steroid on non-retractile prepubertal foreskin by a prospective, randomized, double-blind study. Scand J Urol Nephrol. 2000;34(4):267–9.

    Article  CAS  PubMed  Google Scholar 

  86. Lund L, Wai KH, Mui LM, Yeung CK. An 18-month follow-up study after randomized treatment of phimosis in boys with topical steroid versus placebo. Scand J Urol Nephrol. 2005;39(1):78–81.

    Article  CAS  PubMed  Google Scholar 

  87. Myers JB, Sorensen CM, Wisner BP, Furness PD, Passamaneck M, Koyle MA. Betamethasone cream for the treatment of pre-pubertal labial adhesions. J Pediatr Adolesc Gynecol. 2006;19(6):407–11.

    Article  PubMed  Google Scholar 

  88. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol. 2004;40(6):709–12.

    Google Scholar 

  89. Kim DY, Park HS, Yoon H-S, Cho S. Efficacy of IPL device combined with intralesional corticosteroid injection for the treatment of keloids and hypertrophic scars with regards to the recovery of skin barrier function: a pilot study. J Dermatol Treat. 2015;26(5):481–4.

    Article  Google Scholar 

  90. Jung JY, Roh MR, Kwon YS, Chung KY. Surgery and perioperative intralesional corticosteroid injection for treating earlobe keloids: a Korean experience. Ann Dermatol. 2009;21(3):221–5.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Sardesai VR, Kolte JN, Srinivas BN. A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment. Indian J Dermatol. 2013;58:239.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Torok HM, Jones T, Rich P, Smith S, Tschen E. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12 month treatment for melasma. Cutis. 2005;75:57–62.

    PubMed  Google Scholar 

  93. Jaeger M, Harats M, Kornhaber R, Aviv U, Zerach A, Haik J. Treatment of hypergranulation tissue in burn wounds with topical steroid dressings: a case series. Int Med Case Rep J. 2016;9:241–5.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Ellingsen AR, Thestrup-Pedersen K. Treatment of chronic idiopathic urticaria with topical steroids. Acta Derm Venereol. 1996;76(1):43–4.

    CAS  PubMed  Google Scholar 

  95. Wilson DE, Kaidbey K, Boike SC, Jorkasky DK. Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. Clin Ther. 1998;20(2):299–306.

    Article  PubMed  Google Scholar 

  96. Shukla PN, Gairola M, Mohanti BK, Rath GK. Prophylactic beclomethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study. Indian J Cancer. 2006;43(4):180–4.

    Article  CAS  PubMed  Google Scholar 

  97. Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, et al. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol. 2002;146(6):983–91.

    Article  CAS  PubMed  Google Scholar 

  98. Sakuntabhai A, MacLeod RI, Lawrence CM. Intralesional steroid injection after nerve block anaesthesia in the treatment of orofacial granulomatosis. Arch Dermatol. 1993;129:477–80.

    Article  CAS  PubMed  Google Scholar 

  99. Mignogna MD, Fedele S, Lo Russo L, Adamo D, Satriano A. Effectiveness of small-volume, intralesional, delayed-release triamcinolone injections in orofacial granulomatosis: a pilot study. J Am Acad Dermatol. 2004;51(2):265–8.

    Article  CAS  PubMed  Google Scholar 

  100. Chow KP, Ho CV. Treatment of pyoderma gangrenosum. J Am Acad Dermatol. 1996;34:1047–60.

    Article  CAS  PubMed  Google Scholar 

  101. Ghadially R. Granuloma annulare treatment and management. Drugs Dis. Updated 2016. Available at http://emedicine.medscape.com/article/1123031-treatment. Accessed 10 Jan 2017.

  102. Rallis E, Stavropoulou E, Korfitis C. Granuloma annulare of childhood successfully treated with potent topical corticosteroids previously unresponsive to tacrolimus ointment 0.1%: report of three cases. Clin Exp Dermatol. 2009;34:e475.

    Article  CAS  PubMed  Google Scholar 

  103. Maini P. Intralesional corticosteroid injections as a treatment option for acute lesions in patients diagnosed with hidradenitis suppurativa. J Am Acad Dermatol. 2015;72(5):AB51.

    Google Scholar 

  104. Riis PT, Boer J, Prens EP, Saunte DM, Deckers IE, Emtestam L, et al. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series. J Am Acad Dermatol. 2016;75(6):1151–5.

    Article  CAS  PubMed  Google Scholar 

  105. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol. 1992;72:69.

    CAS  PubMed  Google Scholar 

  106. Khatri KA, Chotzen VA, Burrall BA. Lupus pernio: successful treatment with a potent topical corticosteroid. Arch Dermatol. 1995;131:617.

    Article  CAS  PubMed  Google Scholar 

  107. Prystowsky S, Sanchez M. Management of cutaneous sarcoidosis. Uptodate 2011. Available at http://cursoenarm.net/UPTODATE/contents/mobipreview.htm?21/17/21777/abstract/15.

  108. Lee SJ, Hyun MY, Park KY, Kim BJ. A tip for performing intralesional triamcinolone acetonide injections in acne patients. J Am Acad Dermatol. 2014;71(4):e127–e12.

    Article  PubMed  Google Scholar 

  109. Baharvand M, Sabounchi S, Mortazavi H. Treatment of labial mucocele by intralesional injection of dexamethasone: case series. JDMT. 2014;3(3):128–33.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professor and Head of Dermatology, Sree Balaji Medical College & Hospital, Chromepet, Chennai, India

    Kumar Parimalam

  2. Professor and Head of Dermatology, Kilpauk Medical College, Kilpauk, Chennai, India

    Jayakar Thomas

Authors
  1. Jayakar Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kumar Parimalam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jayakar Thomas .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Apollo Gleneagles Hospitals and WIZDERM, Kolkata, India

    Koushik Lahiri

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Thomas, J., Parimalam, K. (2018). Dermatological Indications and Usage of Topical Corticosteroid. In: Lahiri, K. (eds) A Treatise on Topical Corticosteroids in Dermatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-4609-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4609-4_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4608-7

  • Online ISBN: 978-981-10-4609-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation